Common use of NQSO Grant Clause in Contracts

NQSO Grant. As of August 18, 2015, the Company shall grant Executive a stock option, which will not be an “incentive stock option” (as defined in Section 422 of the Code), under the Company’s 2015 Stock and Stock Option Plan (the “2015 Plan” and together with the 2014 Plan, the “Plans”) to purchase 10,000,000 shares of the Company’s common stock, which shall have a per share exercise price equal to the simple average of the most recent four (4) full trading weeks, weekly VWAPs of the Company’s common stock price immediately preceding the date of grant as reported by OTC IQ. Subject to the accelerated vesting provisions set forth herein, such option will vest as to 25% on each of December 31, 2015, March 31, 2016, June 30, 2016 and September 30, 2016, so that the option will be fully vested and exercisable on September 30, 2016, subject to Executive’s continuous service to the Company through each vesting date. Such option shall have a term of seven (7) years from its date of grant, subject to earlier termination in connection with Executive’s termination of service to the Company as provided in the 2015 Plan and the Option Agreements. If there are insufficient shares in the 2015 Plan to make the grant set forth in this Section 6.3(b) at the Effective Date, the Company will amend the 2015 Plan to increase the number of shares available, and make the grant set forth above, as soon as practical after the Effective Date.

Appears in 2 contracts

Samples: Employment Agreement (Cortex Pharmaceuticals Inc/De/), Employment Agreement (Cortex Pharmaceuticals Inc/De/)

AutoNDA by SimpleDocs

NQSO Grant. As of August 18, 2015, the Company shall grant Executive a stock option, which will not be an “incentive stock option” (as defined in Section 422 of the Code), under the Company’s 2015 Stock and Stock Option Plan (the “2015 Plan” and together with the 2014 Plan, the “Plans”) to purchase 10,000,000 shares of the Company’s common stock, which shall have a per share exercise price equal to the simple average of the most recent four (4) full trading weeks, weekly VWAPs of the Company’s common stock price immediately preceding the date of grant as reported by OTC IQ. Subject to the accelerated vesting provisions set forth herein, such option will vest as to 25% on each of December 31, 2015, March 31, 2016, June 30, 2016 and September 30, 2016, so that the option will be fully vested and exercisable on September 30, 2016, subject to Executive’s continuous service to the Company through each vesting date. Such option shall have a term of seven ten (710) years from its date of grant, subject to earlier termination in connection with Executive’s termination of service to the Company as provided in the 2015 Plan and the Option Agreements. If there are insufficient shares in the 2015 Plan to make the grant set forth in this Section 6.3(b) at the Effective Date, the Company will amend the 2015 Plan to increase the number of shares available, and make the grant set forth above, as soon as practical after the Effective Date.

Appears in 2 contracts

Samples: Employment Agreement (RespireRx Pharmaceuticals Inc.), Employment Agreement (Cortex Pharmaceuticals Inc/De/)

NQSO Grant. As of August 18, 2015, the Company shall grant Executive a stock option, which will not be an “incentive stock option” (as defined in Section 422 of the Code), under the Company’s 2015 Stock and Stock Option Plan (the “2015 Plan” and together with the 2014 Plan, the “Plans”) to purchase 10,000,000 shares of the Company’s common stock, which shall have a per share exercise price equal to the simple average of the most recent four (4) full trading weeks, weekly VWAPs of the Company’s common stock price immediately preceding the date of grant as reported by OTC IQ. Subject to the accelerated vesting provisions set forth herein, such option will vest as to 25% on each of December 31, 2015, March 31, 2016, June 30, 2016 and September 30, 2016, so that the option will be fully vested and exercisable on September 30, 2016, subject to Executive’s continuous service to the Company through each vesting date. Such option shall have a term of seven (7) years from its date of grant, subject to earlier termination in connection with Executive’s termination of service to the Company as provided in the 2015 Plan and the Option Agreements. If there are insufficient shares in the 2015 Plan to make the grant set forth in this Section 6.3(b) at the Effective Date, the Company will amend the 2015 Plan to increase the number of shares available, and make the grant set forth above, as soon as practical after the Effective Date. Upon Executive’s appointment, the Executive shall be eligible to participate in the Plans or any successor plans, subject to the terms of the Plans or successor plans, as determined by the Board, in its discretion.

Appears in 1 contract

Samples: Employment Agreement (Cortex Pharmaceuticals Inc/De/)

AutoNDA by SimpleDocs

NQSO Grant. As of August 18, 2015, the Company shall grant Executive a stock option, which will not be an “incentive stock option” (as defined in Section 422 of the Code), under the Company’s 2015 Stock and Stock Option Plan (the “2015 Plan” and together with the 2014 Plan, the “Plans”) to purchase 10,000,000 shares of the Company’s common stock, which shall have a per share exercise price equal to the simple average of the most recent four (4) full trading weeks, weekly VWAPs of the Company’s common stock price immediately preceding the date of grant as reported by OTC IQ. Subject to the accelerated vesting provisions set forth herein, such option will vest as to 25% on each of December 31, 2015, March 31, 2016, June 30, 2016 and September 30, 2016, so that the option will be fully vested and exercisable on September 30, 2016, subject to Executive’s continuous service to the Company through each vesting date. Such option shall have a term of seven ten (710) years from its date of grant, subject to earlier termination in connection with Executive’s termination of service to the Company as provided in the 2015 Plan and the Option Agreements. If there are insufficient shares in the 2015 Plan to make the grant set forth in this Section 6.3(b) at the Effective Date, the Company will amend the 2015 Plan to increase the number of shares available, and make the grant set forth above, as soon as practical after the Effective Date. Upon Executive’s appointment, the Executive shall be eligible to participate in the Plans or any successor plans, subject to the terms of the Plans or successor plans, as determined by the Board, in its discretion.

Appears in 1 contract

Samples: Employment Agreement (Cortex Pharmaceuticals Inc/De/)

Time is Money Join Law Insider Premium to draft better contracts faster.